Jobs at Eli Lilly and Company

Lead development and scaling of spatial transcriptomics and long-read sequencing platforms for Oncology discovery. Design tissue and library workflows, optimize sample processing, automate NGS protocols, develop image and computational pipelines, integrate multimodal spatial and single-cell data, set QC benchmarks, advise project teams, and mentor junior scientists while managing vendor and collaborator relationships.

Lead litigation and policy strategy involving drug pricing, access, reimbursement, and related federal/state laws. Advise senior leadership and cross-functional teams, manage litigation and investigations, oversee outside counsel and budgets, engage external stakeholders and agencies, monitor legal and policy developments, and identify affirmative litigation and advocacy opportunities to advance market access objectives.

Lead multi-stream UX research programs for digital healthcare products; define research strategy, apply qualitative/quantitative methods, synthesize insights, influence cross-functional decisions, coach researchers, and build scalable research practices with emphasis on ethics, accessibility, and responsible AI use.

Provide medical and scientific leadership for clinical development of oncology/malignant hematology programs: design and review protocols, ensure GCP/regulatory compliance, monitor patient safety and adverse events, support data dissemination, regulatory submissions, investigator engagement, and commercialization strategy. Serve as medical resource across cross-functional teams and represent the product externally to thought leaders and at congresses.

Lead end-to-end commercial assessments for licensing and acquisition opportunities, develop forecasting models, and influence BD leadership through data-driven insights while bridging new markets with comprehensive strategies.

The Clinical Research Lead drives clinical trial execution by engaging investigators, managing sites, and collaborating cross-functionally to optimize enrollment and compliance with protocols in the immunology therapeutic area.